We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.72%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$34B
AUM Growth
+$4.4B
(+15%)
Cap. Flow
+$3.11B
Cap. Flow
% of AUM
9.14%
Top 10 Holdings %
Top 10 Hldgs %
11.75%
Holding
2,403
New
160
Increased
1,020
Reduced
1,025
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$308M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$249M |
| 3 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$221M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$217M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$96.7M |
| 2 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$85M |
| 3 |
AGN
Allergan Inc
AGN
|
+$64.4M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$58.1M |
| 5 |
PepsiCo
PEP
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Technology | 10.33% |
| 4 | Consumer Staples | 8.3% |
| 5 | Industrials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
| $685M | 2.01% |
5,797,055
+2,723,256
| +89% | +$308M |
|
|
2
First Trust Health Care AlphaDEX Fund
FXH
$1.01B
| $558M | 1.64% |
8,319,002
+3,907,859
| +89% | +$249M |
|
|
3
First Trust Consumer Staples AlphaDEX Fund
FXG
$229M
| $477M | 1.4% |
10,694,638
+5,023,736
| +89% | +$221M |
|
|
4
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.84B
| $474M | 1.39% |
7,301,701
+3,430,095
| +89% | +$217M |
|
|
5
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$259M
| $460M | 1.35% |
12,325,608
+5,789,897
| +89% | +$209M |
|
6
Meta Platforms (Facebook)
META
$1.54T
| $356M | 1.05% |
4,332,930
+785,240
| +22% | +$61.5M |
|
7
Alphabet (Google) Class C
GOOG
$3.89T
| $291M | 0.85% |
10,573,971
+1,422,434
| +16% | +$38.1M |
|
8
Amazon
AMZN
$2.51T
| $249M | 0.73% |
13,381,660
+2,497,480
| +23% | +$43.9M |
|
|
PCYC
9
DELISTED
PHARMACYCLICS INC
PCYC
| $230M | 0.68% |
899,700
+74,272
| +9% | +$14.3M |
|
10
BioMarin Pharmaceuticals
BMRN
$11.4B
| $221M | 0.65% |
1,772,096
+595,536
| +51% | +$63.1M |
|
11
Incyte
INCY
$23.3B
| $210M | 0.62% |
2,289,624
+1,048,116
| +84% | +$86.6M |
|
12
Regeneron Pharmaceuticals
REGN
$68.3B
| $209M | 0.61% |
463,697
+133,151
| +40% | +$56.4M |
|
13
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
| $208M | 0.61% |
4,116,033
+472,780
| +13% | +$23.7M |
|
|
ICPT
14
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $180M | 0.53% |
638,274
+361,089
| +130% | +$78.2M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $179M | 0.52% |
1,550,198
+140,640
| +10% | +$16.8M |
|
16
Amgen
AMGN
$201B
| $177M | 0.52% |
1,107,215
+219,864
| +25% | +$34.6M |
|
|
MDVN
17
DELISTED
MEDIVATION, INC.
MDVN
| $171M | 0.5% |
2,651,718
+258,874
| +11% | +$14.8M |
|
18
Charles River Laboratories
CRL
$11B
| $169M | 0.5% |
2,136,663
+514,290
| +32% | +$37.9M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
| $165M | 0.49% |
953,679
+224,852
| +31% | +$40.7M |
|
20
Monster Beverage
MNST
$91.5B
| $165M | 0.49% |
7,158,900
+1,216,140
| +20% | +$25.5M |
|
21
IQVIA
IQV
$34.6B
| $162M | 0.48% |
2,421,744
+467,252
| +24% | +$29.5M |
|
22
eBay
EBAY
$48.5B
| $162M | 0.48% |
6,677,558
+1,176,726
| +21% | +$28.1M |
|
23
United Therapeutics
UTHR
$26.4B
| $160M | 0.47% |
926,320
-29,211
| -3% | -$4.45M |
|
24
Booking.com
BKNG
$134B
| $154M | 0.45% |
3,314,200
+674,100
| +26% | +$30.2M |
|
|
YHOO
25
DELISTED
Yahoo Inc
YHOO
| $152M | 0.45% |
3,418,057
+1,027,560
| +43% | +$46.5M |
|
Similar funds
DAM
First Trust Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, First Trust Advisors held 2,403 positions worth $34B, up 15% from $29.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
First Trust Advisors deployed $3.11B of net new capital in Q1 2015, opening 160 new positions and adding to 1,020 existing holdings. Its largest new stake was Novavax: 705,902 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PepsiCo, an estimated $54.5M trimmed.
- First Trust Advisors's largest Q1 2015 buy was Novavax: 705,902 shares worth $117M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q1 2015, an estimated $308M increase.
- First Trust Advisors's biggest Q1 2015 reduction was PepsiCo, cutting an estimated $54.5M.
- First Trust Advisors fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $96.7M.
- First Trust Advisors's ten largest holdings make up 12% of its $34B portfolio in Q1 2015.
- First Trust Advisors opened 160 new positions and closed 188 in Q1 2015.
- First Trust Advisors's portfolio value rose 15% quarter-over-quarter to $34B.
Based on First Trust Advisors's 13F filing for Q1 2015, filed 4 May 2015.